News & Knowledge Sample Medication Management Guidance Document Many medical offices accept sample medications from pharmaceutical representatives and dispense them to their patients. Providing sample medications to patients in a safe manner requires a diligent, well-managed process. It is important to follow state and federal pharmacy regulations. Detailed policies and procedures should be developed that will address the following areas when accepting and distributing pharmaceutical samples. These policies will provide a set of checks and balances to help prevent medication errors and adverse medication effects from impacting patients. Well-designed policies also will help protect the practice from loss of inventory or illicit pilferage. Effective tracking systems will facilitate awareness of any… Are you a Curi member? The full content of this resource is available only to Curi members. Contact us if you are a member but do not have an account yet, or to learn more about becoming a Curi member. Sign in with Curi - or - Sign in with Constellation Curi’s risk mitigation resources and guidance are offered for educational and informational purposes only. This information is not medical or legal advice, does not replace independent professional judgment, does not constitute an endorsement of any kind, should not be deemed authoritative, and does not establish a standard of care in clinical settings or in courts of law. If you need legal advice, you should consult your independent/corporate counsel. We have found that using risk mitigation efforts can reduce malpractice risk; however, we do not make any guarantees that following these risk recommendations will prevent a complaint, claim, or suit from occurring, or mitigate the outcome(s) associated with any of them. READ NEXT July 1, 2024July 1, 2024Clinical Care | Continuing Medical Education (CME) *NEW* Off Label Drug Use in Every Day Practice In this webinar, Dr. Banker will provide an overview of off label use and the importance of health professionals discussing the science that supports the use of this drug for the patient’s health issue. Read more June 24, 2024June 24, 2024Clinical Care | Hospitals/Health Systems | Patient Management | Risk Management Category II Fetal Heart Rate Tracing Algorithm Guideline Category II fetal heart rate tracings include all FHR tracings not categorized as Category I or Category III. The management of Category II fetal heart rate… Read more June 24, 2024Clinical Care | Hospitals/Health Systems | Patient Management | Risk Management Indications for Placental Pathology Evaluation Guideline The likelihood of litigation is increasing whenever there is a neurologically impaired newborn. Allegations of negligent management of the obstetrical patient, labor, and delivery are the… Read more